compound introduction
2-[4-[4,4-双(4-氟苯基)丁基]-1-哌嗪基]-N-(2,6-二甲基苯基)乙酰胺是一种二芳基甲烷。
CAS number:3416-26-0 molecular formula:C30H35F2N3O
2-[4-[4,4-双(4-氟苯基)丁基]-1-哌嗪基]-N-(2,6-二甲基苯基)乙酰胺是一种二芳基甲烷。
| Chinese alias | - | ||
| English alias | Q6543740 | Angex (TN) | Lidoflazina | SR-01000841235 | Tox21_110533 | HMS2096M03 | 1-Piperazineacetamide, 4-(4,4-bis(4-fluorophenyl)butyl)-N-(2,6-dimethylphenyl)- | HMS3372I14 | Lidoflazina [Italian] | R 7904 | BPBio1_000619 | Corflazine | 4-(4,4-Bis(p-fl | ||
| CAS number | 3416-26-0 | molecular formula | C30H35F2N3O |
| molecular weight | 491.6 | Exact mass | ≥98% |
| PSA | 35.6 | logp | 6 |
| CAS | 3416-26-0 |
| UNII | J4ZHN3HBTE |
| HMDB ID | HMDB0254083 |
| KEGG ID | D04733 |
| ChEBI ID | 93095 |
| Wikidata | Q6543740 |
| ChEMBL ID | CHEMBL92870 |
| Wikipedia | Lidoflazine |
| DrugBank ID | DB13766 |
| DrugCentral | 1580 |
| PharmGKB ID | PA165818137 |
| PubChem CID | 3926 |
| Nikkaji Number | J7.732A |
| NCI 词表代码 | C81685 |
| Pharos Ligand ID | CVQ3SH9S3ZU4 |
| DSSTox Substance ID | DTXSID6045377 |
| Metabolomics Workbench ID | 154546 |
| European Community (EC) Number | 222-312-8 |
| PubChem Reference Collection SID | 504687537 |
| United States Adopted Name (USAN) | LIDOFLAZINE |
| International Nonproprietary Names (INN) | LIDOFLAZINE |
| XLogP3 | XLogP3-AA: 6 |
| 复杂性 | 623 |
| Exact Mass | 491.27481907 |
| 形式电荷 | 0 |
| 重原子计数 | 36 |
| Molecular Weight | 491.6 |
| Monoisotopic Mass | 491.27481907 |
| 可旋转键计数 | 9 |
| 氢键供体计数 | 1 |
| 氢键受体计数 | 5 |
| 共价键单元计数 | 1 |
| 同位素原子计数 | 0 |
| 拓扑极性表面积 | 35.6 Ų |
| 定义键立体中心计数 | 0 |
| 定义原子立体中心计数 | 0 |
| 未定义键立体中心计数 | 0 |
| 未定义原子手性中心计数 | 0 |
No upstream information yet
No downstream information yet